MedTrace Logo

Study of Comparison the Treatment Effect Between Gastric Bypass and Exenatide in Type 2 Diabetes

NCT01435980 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2015-03-27

No results posted yet for this study

Summary

Objectives: To investigate the treatment effect between Gastric Bypass and Exenatide in Type 2 Diabetes in our hospital, in order to investigate the possible mechanism of Gastric Bypass and Exenatide.

Conditions

Interventions

PROCEDURE

Gastric Bypass

basal treatment and Gastric Bypass

DRUG

Exenatide

basal treatment and Exenatide

Sponsors & Collaborators

  • Wu Qinan

    lead OTHER

Principal Investigators

  • liang zi wen, doctor · Third Military Medical University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-02-29
Primary Completion
2016-01-31
Completion
2016-02-29

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01435980 on ClinicalTrials.gov